NCT01439308View on ClinicalTrials.gov

Intranasal SB-705498 in Non-allergic Rhinitis Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

April 30, 2010

Study Completion Date

May 31, 2010

Conditions

Rhinitis

Interventions

DRUG

Placebo

SB-705498 placebo

DRUG

SB-705498

12mg intranasal SB-705498

Trial Locations (1)

1105 AZ

GSK Investigational Site, Amsterdam

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01439308 - Intranasal SB-705498 in Non-allergic Rhinitis Patients | Biotech Hunter | Biotech Hunter